Denali Therapeutics Inc. revenue breakdown overview

Denali Therapeutics Inc. revenue for the last year amounted to 330.53 M USD, the most of which — 330.53 M USD — came from its highest performing source at the moment, Therapeutics, the year earlier bringing 108.46 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Denali Therapeutics Inc. 330.53 M USD, and the year before that — 108.46 M USD.